Skip to Content
Merck
All Photos(1)

Key Documents

EHU123141

Sigma-Aldrich

MISSION® esiRNA

targeting human IFI27

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CTAGGTCAGGGCCACGTAAATTCATTCAGGACAAGCACTGAGGTCAAACTCCCCAGTGATCCTCACCCTCCTCCAGAATTTCCACTTCCCGAAATGAAGCAAAGAGCGGTAGACAGGAGTCATCCCTTCTTGTGGCTCCCAACCTGGGGCAGCCCCCTGCCTCCCTTTAGATGGGCAATCGGCTTAGAAAGTGGAGGGGAAGCCAGTGTGGATCTACTCACAGAATGTTCTTTTGGTTTCCAGCCAGGATTGCTACAGTTGTGATTGGAGGAGTTGTGGCTGTGCCCATGGTGCTCAGTGCCATGGGCTTCACTGCGGCGGGAATCGCCTCGTCCTCCATAGCAGCCAAGATGATGTCCGCGGCGGCCATTGCCAATGGGGGTGGAGTTGCCTCGGGCAGCCTTGTGGCTACTCTGCAGTCACTGGGAGCAACTGGACTCTCCGGATTGACCAAGTTC

Ensembl | human accession no.

ENSG00000165949

NCBI accession no.

NM_001130080

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... IFI27(3429) , IFI27(3429)

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xing Liu et al.
Journal of medical virology, 89(7), 1215-1223 (2016-12-23)
Vaccination against the hepatitis B virus (HBV) is extensively used as an effective method to prevent HBV infection. However, nearly 10% of healthy adults fail to produce a protective level of antibodies against the hepatitis B vaccine, and multiple genetic
Jorge Domínguez-Andrés et al.
Cell metabolism, 29(1), 211-220 (2018-10-09)
Sepsis involves simultaneous hyperactivation of the immune system and immune paralysis, leading to both organ dysfunction and increased susceptibility to secondary infections. Acute activation of myeloid cells induced itaconate synthesis, which subsequently mediated innate immune tolerance in human monocytes. In contrast, induction

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service